Jun 2023 $3 M No. 5 $2 to $10 million 43
Myocardial Solutions, Inc.: Raise no. 5, Jun 2023 × Investors in this round 43 investors had bought by the notice of Jun 30, 2023: 43 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $5 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold debt, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Robert L. Kay · Executive Officer, Director Dane A. Andreeff · Director Gary R. Brock · Director Nelson R. Hill · Director Todd A. Robinson · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering”Signed by Robert L. Kay, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 30, 2023. Read the notice at the SEC .
debt, options SEC Mar 2021 $11 M No. 4 $10 to $50 million 33
Myocardial Solutions, Inc.: Raise no. 4, Mar 2021 × Investors in this round 33 investors had bought by the notice of Mar 23, 2021: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $11 M of $15 M offered; $4 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Denise P. McKenzie · Executive Officer John P. Funkhouser · Executive Officer, Director Dane P. Andreeff · Director Randy P. Hill · Director Todd P. Robinson · Director William P. Burke · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering”Signed by Denise McKenzie, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 23, 2021. Read the notice at the SEC .
equity SEC Dec 2018 $7 M No. 3 $2 to $10 million 26
Myocardial Solutions, Inc.: Raise no. 3, Dec 2018 × Investors in this round 26 investors had bought by the notice of Mar 6, 2019: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Denise A. McKenzie · Executive Officer John P. Funkhouser · Executive Officer, Director Nael A. Osman · Executive Officer Dane A. Andreeff · Director Randy A. Hill · Director Todd A. Robinson · Director William A. Burke · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by John P. Funkhouser, President. Source: SEC Form D and 2 amendments, newest notice filed Mar 6, 2019. Read the notice at the SEC .
equity SEC Jun 2017 $5 M No. 2 $2 to $10 million 37
Myocardial Solutions, Inc.: Raise no. 2, Jun 2017 × Investors in this round 37 investors had bought by the notice of Jul 7, 2017: 37 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Denise P. McKenzie · Executive Officer John P. Funkhouser · Executive Officer, Director Nael P. Osman · Executive Officer Dane P. Andreeff · Director Randy P. Hill · Director Timothy P. McLaughlin · Director William P. Burke · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by John P. Funkhouser, President. Source: SEC Form D, newest notice filed Jul 7, 2017. Read the notice at the SEC .
equity SEC Jun 2016 $4 M No. 1 $2 to $10 million 29
Myocardial Solutions, Inc.: Raise no. 1, Jun 2016 × Investors in this round 29 investors had bought by the notice of Jun 15, 2016: 29 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Denise P. McKenzie · Executive Officer John P. Funkhouser · Executive Officer, Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering.”Signed by Denise McKenzie, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 15, 2016. Read the notice at the SEC .
equity SEC